- Home
- HOTH vs PETZ Comparison
HOTH vs PETZ Comparison
Compare HOTH & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- PETZ
- Stock Information
- Founded
- HOTH 2017
- PETZ 2002
- Country
- HOTH United States
- PETZ China
- Employees
- HOTH N/A
- PETZ N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- PETZ Steel/Iron Ore
- Sector
- HOTH Health Care
- PETZ Industrials
- Exchange
- HOTH Nasdaq
- PETZ Nasdaq
- Market Cap
- HOTH 8.3M
- PETZ 9.3M
- IPO Year
- HOTH 2019
- PETZ 2017
- Fundamental
- Price
- HOTH $1.30
- PETZ $1.07
- Analyst Decision
- HOTH Strong Buy
- PETZ
- Analyst Count
- HOTH 3
- PETZ 0
- Target Price
- HOTH $4.00
- PETZ N/A
- AVG Volume (30 Days)
- HOTH 2.4M
- PETZ 13.7K
- Earning Date
- HOTH 05-12-2025
- PETZ 04-28-2025
- Dividend Yield
- HOTH N/A
- PETZ N/A
- EPS Growth
- HOTH N/A
- PETZ N/A
- EPS
- HOTH N/A
- PETZ 0.26
- Revenue
- HOTH N/A
- PETZ $563,726.00
- Revenue This Year
- HOTH N/A
- PETZ N/A
- Revenue Next Year
- HOTH N/A
- PETZ N/A
- P/E Ratio
- HOTH N/A
- PETZ $5.24
- Revenue Growth
- HOTH N/A
- PETZ 74664.72
- 52 Week Low
- HOTH $0.58
- PETZ $0.65
- 52 Week High
- HOTH $3.80
- PETZ $1.74
- Technical
- Relative Strength Index (RSI)
- HOTH 64.78
- PETZ 58.15
- Support Level
- HOTH $0.88
- PETZ $0.86
- Resistance Level
- HOTH $1.78
- PETZ $1.14
- Average True Range (ATR)
- HOTH 0.16
- PETZ 0.08
- MACD
- HOTH 0.05
- PETZ 0.03
- Stochastic Oscillator
- HOTH 50.72
- PETZ 74.59
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.